Loading...
Revvity, Inc.
RVTY•NYSE
Healthcare
Medical - Diagnostics & Research
$95.53
$-6.44(-6.32%)
Revvity, Inc. (RVTY) AI-Powered Stock Analysis
See how Revvity, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerRevvity, Inc. (RVTY) Stock Overall Grade
Revvity, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
B+
Good
Grade Breakdown by Metric
See how each financial and market factor contributes to Revvity, Inc.'s overall stock rating.
Forecast
A+Score
92/100Financial Growth
C+Score
50/100Fundamental Growth
BScore
67/100Key Ratios
BScore
67/100Sector Comparison
B+Score
75/100Industry Comparison
BScore
65/100S&P 500 Benchmark
AScore
85/100Analyst Consensus
B+Score
71/100Revvity, Inc. (RVTY) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 92/100 (A+), reflecting high confidence in its potential. Financial Growth (50/100, C+) and Fundamental Growth (67/100, B) highlight its stability, while Key Ratios (67/100, B) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (85/100, A), it shows competitive strength. Analyst Consensus (71/100,B+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Revvity, Inc. stock grade, including financials, comparisons, and forecasts.